Showing results (41-50 of 344) with videos related to

Sort By:
Pageof 35
Diabetes Research and Clinical Practice|October 13, 2006
Carotid atherosclerosis associated to metabolic syndrome but not BMI in healthy menopausal womenTiziana Montalcini, Gaetano Gorgone, Carmine Gazzaruso, et al.
BMJ Open Diabetes Research & Care|December 5, 2019
Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damageTeresa Vanessa Fiorentino, Maria Adelaide Marini, Elena Succurro, et al.
Acta Diabetologica|September 22, 2017
Predictors of response to glucagon-like peptide-1 receptor agonists: a meta-analysis and systematic review of randomized controlled trialsMatteo Monami, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes Research and Clinical Practice|June 3, 2021
Depressed myocardial mechano-energetic efficiency in subjects with dysglycemiaTeresa Vanessa Fiorentino, Sofia Miceli, Elena Succurro, et al.
Diabetes/Metabolism Research and Reviews|May 2, 2020
Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose toleranceTeresa Vanessa Fiorentino, Elena Succurro, Angela Sciacqua, et al.
Plos One|June 22, 2017
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individualsFrancesco Andreozzi, Gaia Chiara Mannino, Elettra Mancuso, et al.
Diabetes/Metabolism Research and Reviews|November 1, 2018
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI studyTeresa Vanessa Fiorentino, Elena Succurro, Francesco Andreozzi, et al.
Plos One|February 13, 2014
Association between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver diseaseGiorgio Sesti, Teresa Vanessa Fiorentino, Franco Arturi, et al.
Plos One|August 12, 2014
Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosisGiorgio Sesti, Angela Sciacqua, Teresa Vanessa Fiorentino, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 6, 2019
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin AgentsRaffaella Gentilella, Irene Romera, Claudia Nicolay, et al.
Pageof 35